Introduction
In recent years, it has been suggested that pathogenic signaling excitability could underlie both epilepsy and inherited cardiac arrhythmias, such as long QT syndrome (LQTS) [1] . The LQTS is a rare inherited ion channelopathy characterized by prolonged QT interval, predisposing patients to ventricular arrhythmias that can lead to syncope and sudden cardiac death (SCD) [2] . The three most prevalent genes associated with LQTS are KCNQ1 (LQT type 1), KCNH2 (LQT type 2), and SCN5A (LQT type 3) [3] . From the clinical point of view, LQTS may be misdiagnosed as epilepsy due to seizures triggered by cerebral hypoperfusion during a ventricular arrhythmia. However, some patients can be affected by LQTS and also epilepsy caused by channel dysfunction in myocardial and neuronal cells [4] . Hence, there has been increased interest in a possible association between epilepsy channelopathies and cardiac arrhythmias. Johnson et al. [1] , identified a 'seizure phenotype' in about 30% of unrelated LQTS patients carrying pathogenic variants in the KCNH2 gene. A post-mortem study in diagnosed epileptic samples identified nearly 13% of LQTS pathogenic variants in the KCNH2 and SCN5A genes [5] . A loss-of-function (c.246T>C) pathogenic variation in the KCNH2 gene was also reported in a pedigree featuring LQTS, idiopathic epilepsy, and increased risk of sudden death, supporting a strong link between epilepsy and LQTS [6] .
Sudden unexpected death in epilepsy (SUDEP) is a catastrophic complication of epilepsy, causing up to 20% of patient deaths. However, the pathogenetic mechanisms of this fatal condition remain still unknown [7] . In a recent report of our group, we identified three cases suffering SUDEP who carried genetic variants in the KCNQ1 gene, but consistent relation between both entities remains to be demonstrated [8] . To our knowledge, no report correlates LQTS type 1 and epilepsy in humans so far. We report a family featuring the LQTS and epilepsy due to a pathogenic variant in the KCNQ1 gene.
Methods and results
A 20-year-old soccer player (III-4 in Fig. 1 ) was referred to our unit after detection of prolonged QT interval in a 12-lead ECG performed in a routine medical control (corrected QT 487 ms) (Fig. 1) . He had no family history of sudden death, but his father had been suffering from epilepsy for several years (II-3). We recommended him to stop playing competitive soccer, to avoid drugs that could prolong QT interval and to start treatment with a beta blocker (bisoprolol 5 mg/day). In the follow up visits, six months and a year later, he remained asymptomatic.
The patient's father (II-3 in Fig. 1 ), who was 47 years old, had 12-lead ECG showing a prolonged QT interval (Bazett corrected QT of 476 mseg). He was diagnosed of focal epilepsy at the age of 16. He had prodromal symptoms seconds before losing consciousness, and, just at the first signs, he preventively placed his wallet in his mouth to protect himself from biting. He noticed tingling around his mouth, his hands and progressively his arms, neck and head, with a subsequent tonic-clonic seizure. He was seizure-free on carbamazepine until, the age of 25 years, when his neurologist withdrawn the antiepileptic therapy. We recommended him to avoid drugs that could prolong the QT interval and start treatment with a beta blocker (bisoprolol 5 mg/day). In the follow up visits six months and a year later he has remained asymptomatic.
The remaining first-degree family members were asymptomatic and had normal QT interval on their ECG. Patient I-1 died from pulmonary infection at 82 years of age. Patient I-4 died from myocardial infarction at 84 years of age.
We performed a direct sequencing analysis of KCNQ1, KCNH2, KCNE1, KCNE2 and SCN5A genes in the proband and identified a non-synonymous heterozygous missense pathogenic variant (c.817C>T) in exon 6 of the KCNQ1 gene (Fig. 1) . The variant had been previously reported in Human Gene Mutation Database -HGMD (http://www.hgmd.cf.ac.uk/ac/index.php), and associated with LQTS (rs120074180, CM960899) [9, 10] . The variant is conserved in many species suggesting that this region has structural or functional importance (http://www.uniprot.org/). In addition, it is absent in exome variant server (http://evs.gs. washington.edu/EVS/) and 1000 genomes (http://www. 1000genomes.org/) databases, suggesting to be an uncommon genetic variant in the population. Finally, in silico prediction in PROVEAN (Protein Variation Effect ANalyzer) (http://provean.jcvi. org/index.php), Mutation Taster (http://www.mutationtaster.org/ ), and PolyPhen2 (http://genetics.bwh.harvard.edu/pph2) databases predicted a pathogenic/deleterious effect. No other noncommon (MAF > 1%) genetic variants were identified in index case. After that, a genetic test was performed in close relatives (Fig. 1) . The same variant p.L273F_KCNQ1 was identified in the father of the proband (II-3), but not in the other tested relatives.
Discussion
In recent years, there has been an increased interest on cardiac alterations in patients affected by epilepsy. Despite similar molecular pathophysiology, ion channelopathies, separation of phenotypes may be due to organ-specific gene expression [11, 12] . So far, numerous pathogenic variants have been identified in patients suffering cardiac arrhythmia and epilepsy, mainly in the SCN5A and KCNH2 genes [13, 14] . A study performed in mouse lines bearing dominant pathogenic variants in the Kv1.1 Shaker-like potassium channel, associated with LQTS type 1 in humans, showed epilepsy and premature death [15] , supporting that arrhythmogenic cardiac variants in this ion channel might also cause epileptic changes in brain [13] . Recently, a collaborative study from our group genetic variants in the KCNQ1 gene in a large series of subjects featuring epilepsy or a family history of sudden death, although the absence of a family study did not allow a definite causal correlation [8] . Hence, a consistent association between KCNQ1 and LQT/epilepsy remains to be demonstrated. Here we report a family showing the association of epilepsy concomitant with LQTS. In our patients, prolonged QT interval supported the phenotype. On the other hand the genetic pathogenicity of p.L273F_KCNQ1 has been confirmed as previously reported in LQTS cases [9, 10] . In addition, the evolutionary conservation of the residue and its absence in healthy controls as well as in silico deleterious prediction supports its pathogenic/ deleterious role. Despite cardiac arrhythmias and epilepsy can be misdiagnosed due to similar clinical manifestations, the father of our proband showed clear clinic features of epilepsy with focal onset and secondarily generalized seizure. Notably, in the series from Partemi et al. [8] , all the 3 patients carrying a change in KCNQ1 suffered from epilepsy of focal type, according to the present case. In this family, the variable clinical expression, with no reported seizures in the proband may be explained by an age-dependent expression of KCNQ1 potential pathogenic variants and/or by the influence of additional genetic modifiers [16] .
[ ( F i g . _ 1 ) T D $ F I G ]
In summary, although our family does not necessarily provide the definite evidence for a link between LQTS and epilepsy, it further supports the view that KCNQ1 genetic variations may confer susceptibility for recurrent seizure activity increasing the risk or lead to sudden death, according to the cardiocerebral channelopathy theory [11, 17] . While further studies in large cohorts will be needed to be performed to clarify the correlation between cardiac and brain channelopathies, the identification of genetic variants which may cause SCD and epilepsy brings into question the need of simultaneous EEG and ECG recording with video-monitoring to elucidate a possible link between cardiac arrhythmia and epilepsy [18] .
